Diopsys, Inc is a medical instrumentation company dedicated to delivering high-quality, cost-effective preventative health care.  We specialize in the development and marketing of patient-friendly, non-invasive diagnostic vision testing equipment utilizing Evoked Potential technology.  Diopsys has developed and markets the patented Enfant^® Pediatric VEP Vision Testing System, a device used in testing for visual deficits, including amblyopia, in children as young as six months of age. Diopsys also developed and markets the Diopsys™ NOVA-DT and Diopsys™ NOVA-TR VEP Vision Testing Systems utilized by ophthalmologists and optometrists for the detection, diagnosis and treatment of vision disorders.


Eye-Opening Facts about Amblyopia in Children

♦ More commonly referred to as "lazy eye," amblyopia is decreased vision that results when one (or both) eyes sends a blurry image to the brain, inhibiting development of the vision system.

♦ According to the U.S. Preventive Services Task Force, amblyopia is the most common vision problem in children; an estimated 4 out of every 100 children under age six have amblyopia.

♦ Prevent Blindness America says that only 1 in 5 children in the U.S. have a vision test before kindergarten.

♦ The Children's Eye Foundation estimates that 4.5 million adults are legally blind or visually incapacitated in at least one eye due to amblyopia that was left untreated.

To learn more about how Diopsys VEP Vision Tests can help detect visual deficits early, choose from the toolbars above.